原发免疫缺陷病DOCK8缺陷综合征及IKBKB缺陷疾病的发病机制探讨
[Abstract]:In the first part of the DOCK8 deficiency, follicular assisting T cells to produce the mechanism of IL-21 regulation of Ig E: high Ig E syndrome (Hyper-Ig E syndrome, HIES) is a group of autosomal primary immunodeficiency diseases, including the autosomal recessive inheritance (AR) Yndrome, DIDS; OMIM 243700) is a primary immunodeficiency disease characterized by atopic dermatitis, recurrent, chronic skin virus infection and respiratory infection. The.DOCK8 gene of serum LG E and eosinophils is a primary immunodeficiency disease, which is located on the human chromosome 9 of human chromosome p24.3, and its encoded DOCK8 protein activates the Rho-GTP enzyme, thus regulating many of them. The cell function, especially the actin cytoskeleton regulation, affects the joint immunodeficiency in the cell migration.DOCK8 deficiency patients, but the B cell mediated antibody defects are most prominent, especially the rapid rise of Ig E level, and the present mechanism is unknown. Objective: to analyze the clinical manifestation and immunity of children with DOCK8 deficiency syndrome in China. Function, using clinical samples and DOCK8-KO mouse model to explore the effect of DOCK8 protein deficiency on the level of Ig E and its mechanism. Methods: high throughput sequencing and flow cytometry were used to diagnose children with suspected high Ig E syndrome, and the lymphocyte immune function evaluation was established after the diagnosis of DOCK8 defect, and the children and the healthy same age control were analyzed. The number and function of T cells were assisted by peripheral blood follicles, as well as the IL-21 level of its related functional molecules, and the expression of Bcl-6 and Blimp-1 m RNA were detected by real time fluorescence. The TALEN technique was used to establish the DOCK8-KO mouse model and evaluate its immune function. The function of the follicle assisted T cells was changed, and the related functional molecules ICOS, PD-1, Bcl were analyzed. At the level of -6 and IL-21, the DOCK8-KO mice were treated with IL-21 replacement therapy and their effects on the immune function were observed. Further construction of OVA induced asthma DOCK8-KO mice model and IL-21 supplementation were carried out to analyze the therapeutic mechanism. Results: 1.7 cases of DOCK8 immunodeficiency children, 2 men and 5 women, and high Ig E syndrome NIH score were all higher than 40 points. For repeated stubborn virus infection, pneumonia, abnormal increase of serum Ig E and eosinophils. High throughput sequencing analysis of DOCK8 single gene showed that 7 children had different degrees of large fragment deletion, code mutation or missense mutation, all of which were unreported new mutations. Among them, children with P1 were exon 19-48. C.5842 del G, C 5843CA p.A1948fs X1953, loss of homozygosity in exon 11 of P2 children, loss of heterozygosity in exon 12-33 of children with P2 (c.3152del G, c.3152del G p.S1051fs) and missense mutations were found in children with exon 2, 1 and 3-39. The heterozygosity of exon was absent, the children of P6 were homozygous deletion of exon 7 and heterozygosity in exon 8-10, and P7 children were transferred code mutation (c.1278-1279 del TG p.V427fs X435) with.7 cases complete flow cytometry and Western detection, and peripheral blood mononuclear cells had no DOCK8 egg white expression. The.T cell deletion ring (TRECs) was reduced to some extent, the proliferation level of lymphocyte and the cytotoxic function of NK cells were significantly lower than those of normal age children. The regulatory B cells in peripheral blood were low, and regulatory T cells, CD4+T cells produced cytokine IL-17, IL-4 and IFN- gamma water were normal.DOCK8 children with follicular auxiliary T. There was no statistical difference in the ratio of cell CD4+T cells to normal people, but the absolute value was significantly lower than that of normal controls. Especially, the IL-21 secreted by Tfh cells significantly decreased.2. (1) using TALEN technology to establish DOCK8-KO mice, the Ig E of the DOCK8-KO mice and the Ig E+B cells in the blood and spleen, and the statistical difference between the DOCK8-KO mice and the WT mice. The follicle assisted T cell related functional molecules in different.DOCK8-KO mice decreased to varying degrees, in which the level of cytokine IL-21 decreased significantly, the main regulating transcription factor Bcl-6 of Tfh cell differentiation, and the PD-1 of Tfh cells, the level of ICOS were reduced in varying degrees. (2) the low dose OVA of traditional dose 1/4 was used. The DOCK8-KO mouse asthma model was successfully induced. The model mice had obvious abnormal pulmonary function, the level of serum Ig E increased, the eosinophil increased, and the level of Ig E+B cells in DOCK8-KO and WT mice induced by.OVA was increased, but the level of the former was several times that of the latter, and the serum total Ig E and OVA specificity Ig. The level of horizontal elevation was particularly obvious. The IL-21 level of DOCK8-KO mice induced by OVA was further decreased, while the WT mice induced by OVA did not change obviously. In addition, the OVA induced DOCK8-KO mouse spleen memory Tfh cells, the main regulating transcription factor Bcl-6 of the Tfh cell differentiation, and the functional molecular PD-1 of the Tfh cells were significantly reduced. 3. (1) the recombinant mouse IL-21 cytokine (20ng/d x 3-6 days) was used to replace the DOCK8-KO mice. It was found that the serum Ig E level of the KO mice could almost revert to the normal level. The spleen Tfh cells and the main regulating transcription factor Bcl-6 of the splenic Tfh cells, as well as the Tfh cell functional molecules PD-1 and ICOS were all able to recover to the normal level to the normal level. Level, treatment effect is very obvious. (2) the use of IL-21 to treat OVA induced mouse model, WT mice Ig E level although there is a response, but the overall treatment effect is not as obvious as DOCK8-KO mice. OVA induced DOCK8-KO mice after IL-21 treatment of Ig E level can be back to normal levels, and Tfh cells and the main regulation of transcription factors, And the functional molecules of Tfh cells, PD-1, and ICOS can rise to the normal level in varying degrees. Conclusion: DOCK8 defects cause the development and differentiation of Tfh cells and the decrease of IL-21 secretion, which may be the root cause of the uncontrolled reaction of the B cells to the allergen reaction and the production of a large number of functional Ig E. The background of the influence of the second part IKK beta defect on NF- nuclear B is: Gene mutation is a special kind of joint immunodeficiency disease, which is characterized by repeated bacteria, virus and fungal infection. Most patients have different degrees of thrush, bronchitis and pneumonia, accompanied by chronic diarrhea, growth retardation, cerebral hemorrhage, epilepsy, cord inflammation, and delay of umbilical cord abscission. The.IKBKB gene is located in human 8. P11.2, its encoded IKK beta protein is one of the subunits of I kappa B kinase, which is mainly involved in the activation process of NF- kappa B pathway, and activated IKK phosphorylation I kappa B alpha (NF- kappa B). Objective: to analyze the clinical manifestation, protein expression, gene mutation and immune function of a patient with IKBKB mutation. The effect and mechanism of the 395 site amino acid phosphorylation on NF- kappa B nucleation and pathway function. Methods: children, 17 years old, 2 month old after birth, recurrent respiratory infection, diarrhea and low weight. High throughput sequencing IKK beta protein was detected by flow cytometry and immunoblotting. Flow cytometry and immunoblotting were used to detect IKK beta protein. Flow cytometry was used to analyze lymphocyte function and EMSA method was used to detect the level of NF- kappa B. The site directed mutated cell line of 395 loci was prepared to remove the phosphorylation of the site and the mechanism of its effect on the stability of IKK beta protein was discussed. Result: high throughput sequencing showed that the IKBKB gene occurred missense mutation (c.1183TC, p.Y395H), which was a new mutation that had not been reported. One generation sequencing verification confirmed the mutation of the site. The expression of IKK beta protein was not detected by flow cytometry and immunoblotting. The immune function evaluation found that the children's memory B cells were extremely low, and the regulatory T cells were absent. The level of lymphocyte proliferation was significantly impaired. Regulatory B cells were elevated, while CD4+T cells expressed cytokine IL-17, IL-4, IL-21 and IFN- gamma in the normal lower limit. The cytotoxic function of NK cells and the diversity of TCRV beta were normal. The protein of NF- kappa B in the nucleus of the children was lower than that of the normal human, suggesting that the gene mutation leads to NF- kappa B. IKK beta degradation rate increased rapidly and protein stability decreased after the 395 site mutation resulted in the disappearance of phosphorylation sites. Conclusion: 1 cases of extremely rare cases of IKBKB were diagnosed, and the missense mutation of the 395 site of.IKK beta in tenth cases of.IKK was reported worldwide for the first time. This site is an important phosphorylation site for IKK beta protein. The amino acid change caused by mutation of tyrosine to histidine leads to the loss of phosphorylation sites and the rapid degradation of the amino acid, which ultimately affects the nucleation of NF- kappa B.
【学位授予单位】:重庆医科大学
【学位级别】:博士
【学位授予年份】:2016
【分类号】:R725.9
【相似文献】
相关期刊论文 前10条
1 刘颖中;刘钢;江载芳;;儿童原发免疫缺陷病72例临床分析[J];中国实用儿科杂志;2007年08期
2 ;小儿免疫和免疫缺陷病[J];中国医学文摘(儿科学);2008年01期
3 ;小儿免疫和免疫缺陷病[J];中国医学文摘(儿科学);2008年05期
4 郭履峈;免疫缺陷病与感染(综述)[J];国外医学(儿科学分册);1979年02期
5 Bortin;陈紫榕;;严重混合型免疫缺陷病的特征及其用移植治疗的结果[J];福建医药杂志;1979年01期
6 富永宪治;谷洪喜;;续发性免疫缺陷病[J];国外医学(免疫学分册);1980年05期
7 Polmar SH;王自求;;免疫缺陷病的代谢异常[J];国外医学(免疫学分册);1980年05期
8 史久华;;免疫缺陷病与恶性肿瘤[J];国外医学(免疫学分册);1980年05期
9 Polmar SH;章有章;;免疫缺陷病的代谢概况[J];国外医学(分子生物学分册);1981年02期
10 吴梓梁;;免疫缺陷病[J];实用儿科临床杂志;1987年01期
相关会议论文 前8条
1 张金;刘钢;贺建新;;免疫缺陷病儿童感染特征研究[A];中华医学会第十七次全国儿科学术大会论文汇编(上册)[C];2012年
2 陈香元;曾华松;韦茹;曾萍;李丰;;儿童原发免疫缺陷病110例临床特点及基因分析[A];中华医学会第十五次全国儿科学术大会论文汇编(上册)[C];2010年
3 陈香元;曾华松;;儿童原发免疫缺陷病110例临床特点及基因分析[A];中华医学会2011年全国变态反应学术会议论文集[C];2011年
4 贺建新;刘秀云;徐保平;胡英惠;申昆玲;江载芳;;儿童普通变异性免疫缺陷病9例临床及免疫特点分析[A];中华医学会第十三届全国儿科呼吸学术会议论文汇编[C];2012年
5 卢俊;胡绍燕;薛胜利;;先天性中性粒细胞减少症的诊治——附四例报告[A];2012年江浙沪儿科学术年会暨浙江省医学会儿科学分会学术年会、儿内科疾病诊治新进展国家级学习班论文汇编[C];2012年
6 钟华;郝飞;阎衡;叶庆佾;钟白玉;杨希川;赵文利;周平;孟刚;;婴儿先天性免疫缺陷病合并播散性马尔尼菲青霉、白色假丝酵母感染一例报告[A];中华医学会第十二次全国皮肤性病学术会议论文集[C];2006年
7 王春华;;《X、L、P》病分类的商榷[A];第五届全国病案管理学术会议论文集[C];1995年
8 朱少华;秦启生;陈晓瑞;;联合性免疫缺陷病接种卡介苗猝死一例[A];第五次全国法医学术交流会论文集[C];1996年
相关重要报纸文章 前6条
1 记者 胡德荣;一罕见儿童免疫缺陷病研究获突破[N];健康报;2014年
2 本报记者 郭小伟;24小时为患者开机[N];重庆日报;2010年
3 沈权民;儿童免疫缺陷怎么办?[N];大众卫生报;2004年
4 身体周刊记者 肖蓓;陈同辛:为儿童免疫功能“补缺”[N];东方早报;2013年
5 韩成;一个基因缺陷导致两种免疫病[N];中国医药报;2005年
6 王小衡;孩子缘何弱不禁风[N];大众卫生报;2005年
相关博士学位论文 前1条
1 秦涛;原发免疫缺陷病DOCK8缺陷综合征及IKBKB缺陷疾病的发病机制探讨[D];重庆医科大学;2016年
,本文编号:2152047
本文链接:https://www.wllwen.com/yixuelunwen/eklw/2152047.html